维普中文期刊产品整合服务
18篇 您的检索式:作者名="Kayani I"
    题名 作者 年代 出处 被引量
1The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy显示文摘Srirajaskanthan R Kayani I Quigley AM 2010J Nucl Med2010,51,6:1
2Functional ima- ging of neuroendocrinc tumors with combined PET/CT using ^68Ga -DOTATATE ( Dota-DPhe^1, Tyr^3 -octreotate )and ^18F-FDG显示文摘KAYANI I BOMANJI J B GROVES A 2008Cancer2008,112,11:1
3The role of 6s Ga - DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on ul In - DTPA - octreotide seintigraphy显示文摘Srirajaskanthan R Kayani I Quigley AM 2010J Nucl Med2010,51,6:1
4The role of 68Ga - DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 1u In- DTPA -octreotide seintigraphy 显示文摘Srirajaskanthan R Kayani I Quigley AM 2010J Nucl Med2010,51,6:1
5A comparison of 68Ga - DOTATATE and lS F - FDG PET/CT in pulmonary neuroendocrine tumors显示文摘Kayani I Conry BG Groves AM 2009J Nucl Med2009,50,12:1
6Sequential FDG-PET/CT as abiomarker of response to sunitinib in m etastatic clear cell renalcancer显示文摘Kayani I Avril N Bomanji J 2011Clin Cancer Res2011,17,18:1
7Oral contrast medium in PET/CT: should you or shouldn't you? 显示文摘Groves AM Kayani I Dickson JC 2005Eur J Nucl Med Mol Imaging2005,32,10:1
8Oral contrast medium in PET/CT: should you or shouldn't you?显示文摘Groves AM Kayani I Dickson JC 2005Eur J Nucl Med Mol Imaging2005,32,10:1
9A comparison ofFDG-PET/CT in pulmonary neuroendocrinetumors显示文摘Kayani I Conry BG Groves AM 2009J Nucl Med2009,50,22:1
10The Role of 68Ga- DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111 In - DTPA - Oetreotide Scintigraphy 显示文摘SRIRAJASKANTHAN R KAYANI I QUIGLEY AM 2010J Nuel Med2010,51,6:1
11Pregnancy outcome in se- vere placental abruption显示文摘Kayani S I Walkinshaw S A Preston C 2003BJOG2003,110,7:1
12Sequential FDG- PET/CT as a biomarker of response to Sunitinib in me- tastatic clear cell renal cancer显示文摘Kayani I Avril N Bomanji J 2011Clin Cancer Res2011,17,18:1
13The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer 显示文摘Powles T Kayani I Blank C 2011Ann Oncol2011,22,5:1
14The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on ^111In-DTPA-oetreotide seintigraphy显示文摘Srirajaskanthan R Kayani I Quigley AM 2010J Nucl Med2010,51,:1
15The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer显示文摘Powles T Kayani I Blank C et at 2011Annals of Oncology2011,22,5:1
16The potential advantages of (18) FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer显示文摘Moule RN Kayani I Moinuddin SA 2010Radiother Oncol2010,97,2:1
17Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable sal- vage in relapsed patients after T-cell-depleted allogeneic transplan- tation for Hodgkin's lymphoma显示文摘Peggs KS Kayani I Edwards N 2011J Clin Oncol2011,29,8:1
18The Role of 68Ga- DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111 In - DTPA - Octreotide Scintigraphy 显示文摘Srirajaskanthan R Kayani I Quigley AM 2010J Nu- cl Med2010,51,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费